These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 8458362)
61. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)]. Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211 [TBL] [Abstract][Full Text] [Related]
62. [The angiotensin-converting enzyme inhibitor in the treatment of angina pectoris]. Bussmann WD; Wittig RA; Brunner I; Bahrmann H Dtsch Med Wochenschr; 1992 Apr; 117(16):603-6. PubMed ID: 1568426 [TBL] [Abstract][Full Text] [Related]
63. An open, parallel group comparison of quinapril and captopril, when added to diuretic therapy, in the treatment of elderly patients with heart failure. Beynon JH; Pathy MS Curr Med Res Opin; 1997; 13(10):583-92. PubMed ID: 9327193 [TBL] [Abstract][Full Text] [Related]
64. ACE inhibitors in the treatment of hypertension in the older patient. Canter D; Frank G Eur Heart J; 1990 May; 11 Suppl D():33-43. PubMed ID: 2193809 [TBL] [Abstract][Full Text] [Related]
65. The safety and efficacy of quinapril in the treatment of mild to moderate essential hypertension. Frishman WH Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII19-25. PubMed ID: 2189617 [TBL] [Abstract][Full Text] [Related]
67. [Conversion from oral ACE inhibitor to intravenous quinaprilat administration in mild to moderate essential hypertension]. Schmidt BM; Smilde J; Oldenbroek C; Wehling M Med Klin (Munich); 1998 Dec; 93(12):701-6. PubMed ID: 10024837 [TBL] [Abstract][Full Text] [Related]
68. Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor. Gupta RK; Kjeldsen SE; Krause L; Kneisley J; Posvar E; Weder AB; Julius S Clin Pharmacol Ther; 1990 Jul; 48(1):41-9. PubMed ID: 2196144 [TBL] [Abstract][Full Text] [Related]
69. Quinapril. A review of its pharmacological properties, and therapeutic efficacy in cardiovascular disorders. Wadworth AN; Brogden RN Drugs; 1991 Mar; 41(3):378-99. PubMed ID: 1711445 [TBL] [Abstract][Full Text] [Related]
70. Evaluation of quinapril on regional blood flow and cardiac function in patients with congestive heart failure. Munger MA; Chance M; Nair R; Prescott AW; Nara AR; Simonson MS; Green JA; Posvar EL J Clin Pharmacol; 1992 Jan; 32(1):70-6. PubMed ID: 1740540 [TBL] [Abstract][Full Text] [Related]
71. Effect of ACE inhibitors on angiographic restenosis after coronary stenting (PARIS): a randomised, double-blind, placebo-controlled trial. Meurice T; Bauters C; Hermant X; Codron V; VanBelle E; Mc Fadden EP; Lablanche J; Bertrand ME; Amouyel P Lancet; 2001 Apr; 357(9265):1321-4. PubMed ID: 11343737 [TBL] [Abstract][Full Text] [Related]
72. Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: randomised, placebo controlled trial. Lough M; Cleland J; Langan J; Cowley A; Wade A BMJ; 1998 Nov; 317(7169):1352-3. PubMed ID: 9812933 [No Abstract] [Full Text] [Related]
73. [Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study]. Skvortsov AA; Nasonova SN; Sychev AV; Orlova IaA; Baklanova NA; Masenko VP; Mareev VIu; Belenkov IuN Kardiologiia; 2006; 46(7):33-51. PubMed ID: 16883264 [TBL] [Abstract][Full Text] [Related]
75. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2]. Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227 [TBL] [Abstract][Full Text] [Related]
76. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial. Pepine CJ; Rouleau JL; Annis K; Ducharme A; Ma P; Lenis J; Davies R; Thadani U; Chaitman B; Haber HE; Freedman SB; Pressler ML; Pitt B; J Am Coll Cardiol; 2003 Dec; 42(12):2049-59. PubMed ID: 14680725 [TBL] [Abstract][Full Text] [Related]
77. A single (investigator)-blind randomised control trial comparing the effects of quinapril and nifedipine on platelet function in patients with mild to moderate hypertension. Islim IF; Bareford D; Beevers DG Platelets; 2001 Aug; 12(5):274-8. PubMed ID: 11487379 [TBL] [Abstract][Full Text] [Related]
78. Quinapril hydrochloride effects on renal function in patients with renal dysfunction and hypertension: a drug-withdrawal study. Miller MA; Texter M; Gmerek A; Robbins J; Shurzinske L; Canter D Cardiovasc Drugs Ther; 1994 Apr; 8(2):271-5. PubMed ID: 7918140 [TBL] [Abstract][Full Text] [Related]
79. Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation. Torsello A; Locatelli V; Cella SG; Sanguini AM; Berti F J Endocrinol Invest; 2003 Jan; 26(1):79-83. PubMed ID: 12602539 [TBL] [Abstract][Full Text] [Related]
80. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia. Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]